3/6/2013

The FDA approved Dako's HercepTest and HER2 IQFISH pharmDx tools as companion diagnostics for Kadcyla, or ado-trastuzumab emtansine, a drug for HER2-positive metastatic breast cancer from Genentech. The agency also approved Kadcyla.

Related Summaries